F. Amant
New England Journal of Medicine · 2010–2017
A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from F. Amant's perspective
Ordered by how strongly the researchers F. Amant trusts endorse each paper. Same corpus, a different order for every researcher.
- Integrated Genomic Characterization of Endometrial Carcinoma (Nature)
- Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. (The Lancet)
- Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (Annals of Oncology)
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
- Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft (Nature)
- Single-cell dissection of transcriptional heterogeneity in human colon tumors (Nature Biotechnology)
- Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. (Clinical Infectious Diseases)
- Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study (The Lancet)
- Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. (Gynecologic Oncology)
Their papers
- Interrogating open issues in cancer precision medicine with patient-derived xenografts (2017) — 601 citations
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer (2015) — 904 citations
- ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. (2015) — 642 citations
- Patient Derived Xenograft Models: An Emerging Platform for Translational Cancer Research (2014) — 1,525 citations
- Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. (2010) — 2,377 citations